Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models

Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43. doi: 10.1089/ars.2012.4858. Epub 2012 Oct 12.

Abstract

Significance: Schizophrenia (SZ) and bipolar disorder (BD) are classified as two distinct diseases. However, accumulating evidence shows that both disorders share genetic, pathological, and epidemiological characteristics. Based on genetic and functional findings, redox dysregulation due to an imbalance between pro-oxidants and antioxidant defense mechanisms has been proposed as a risk factor contributing to their pathophysiology.

Recent advances: Altered antioxidant systems and signs of increased oxidative stress are observed in peripheral tissues and brains of SZ and BD patients, including abnormal prefrontal levels of glutathione (GSH), the major cellular redox regulator and antioxidant. Here we review experimental data from rodent models demonstrating that permanent as well as transient GSH deficit results in behavioral, morphological, electrophysiological, and neurochemical alterations analogous to pathologies observed in patients. Mice with GSH deficit display increased stress reactivity, altered social behavior, impaired prepulse inhibition, and exaggerated locomotor responses to psychostimulant injection. These behavioral changes are accompanied by N-methyl-D-aspartate receptor hypofunction, elevated glutamate levels, impairment of parvalbumin GABA interneurons, abnormal neuronal synchronization, altered dopamine neurotransmission, and deficient myelination.

Critical issues: Treatment with the GSH precursor and antioxidant N-acetylcysteine normalizes some of those deficits in mice, but also improves SZ and BD symptoms when given as adjunct to antipsychotic medication.

Future directions: These data demonstrate the usefulness of GSH-deficient rodent models to identify the mechanisms by which a redox imbalance could contribute to the development of SZ and BD pathophysiologies, and to develop novel therapeutic approaches based on antioxidant and redox regulator compounds.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bipolar Disorder / genetics
  • Bipolar Disorder / metabolism*
  • Bipolar Disorder / physiopathology
  • Brain / metabolism
  • Brain / pathology
  • Brain / physiopathology
  • Disease Models, Animal*
  • Gene Knockout Techniques
  • Glutamate-Cysteine Ligase / genetics
  • Glutathione / deficiency
  • Humans
  • Oxidation-Reduction
  • Polymorphism, Single Nucleotide
  • Schizophrenia / genetics
  • Schizophrenia / metabolism*
  • Schizophrenia / physiopathology
  • Synaptic Transmission

Substances

  • Glutamate-Cysteine Ligase
  • Glutathione